Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): Inhibition of cyclooxygenase and induction of NSAID-activated gene

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 3, 2002, Pages 1126-1131

  Baek, Seung Joon ^a   Wilson, Leigh C ^a   Lee, Chang Ho ^a   Eling, Thomas E ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Gangneung Wonju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

ARTICLE; CANCER PREVENTION; CELL LINE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DINOPROSTONE; GENE EXPRESSION REGULATION; HUMANS; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED;

EID: 0036260962     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.3.1126     Document Type: Article

References (45)

1. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: Important role of RNA stabilization
2. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3
3. Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has pro-apoptotic and antitumorigenic activities
4. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
5. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes
6. Inhibition of lung tumorigenesis by NSAIDS: A working hypothesis
7. Mechanism underlying nonsteroidal antiinflammatory drug-mediated apoptosis
8. Nonsteroidal anti-inflammatory drug use and breast cancer risk
9. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin
10. NSAIDs upregulate β2-integrin expression on human neutrophils through a calcium-dependent pathway
11. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
12. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines
13. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
14. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53
15. Prostaglandin synthase 2
16. PLAB, a novel placental bone morphogenetic protein
17. Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells
18. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
19. Inhibition of NF-κB by sodium salicylate and aspirin
20. Identification of a novel member of the TGF-β superfamily highly expressed in human placenta
21. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
22. Placental TGF-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression
23. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
24. Aspirin prevents tumors in a murine model of familial adenomatous polyposis
25. Indomethacin reduces lung adenoma number in A/J mice
26. Cyclooxygenase-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines
27. Proapoptotic anti-inflammatory drugs
28. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells
29. Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family
30. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
31. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
32. Cell-type-specific activation of c-Jun N-terminal kinase by salicylates
33. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
34. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
35. Ibuprofen: New explanation for an old phenomenon
36. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
37. PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
38. Aspirin use and risk of fatal cancer
39. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
40. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism
41. Meloxicam inhibits the growth of non-small cell lung cancer
42. Nonsteroidal anti-inflammatory drugs enhance glutathione S-transferase theta levels in rat colon
43. Cyclooxygenase 1 and 2
44. R-Flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: Implications for prophylaxis and treatment of colon cancer
45. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse